The IHC results indicated that the expressionof PCNA was significantly decreased in the μsPEFs treated groupcompared to the sham and control groups (both p < 0.001) (Figure 6), suggesting that the μsPEFs treatment inhibittumor cells proliferation after tumor ablation in vivo. The gene discussed is PCNA; the disease is neoplasm.